[
  {
    "question_id": "biology_34_q1",
    "model_answer": "answer: A\n\nThe speaker in event 3 mentions using phenylephrine to dilate the pupils during an eye exam. This statement is directly supported by event 2, where the narrator defines phenylephrine as a sympathomimetic adrenergic receptor agonist that causes pupillary dilation by acting on iris smooth muscle. Therefore, event 2 provides the causal basis for the clinical use of phenylephrine mentioned in event 3.",
    "choices": [
      "A"
    ]
  },
  {
    "question_id": "biology_34_q2",
    "model_answer": "The correct answer is A, B, and C.\n\nEvent 9 explains that muscarinic receptor agonists produce parasympathetic effects, which include decreased heart rate due to receptor activation in the heart. This establishes the normal function of muscarinic receptors and their effect on heart rate.\n\nEvent 10 clarifies that a muscarinic acetylcholine receptor antagonist is called a parasympatholytic/anticholinergic drug. This provides context about the nature of atropine as an antagonist.\n\nEvent 11 identifies atropine as an anticholinergic muscarinic receptor antagonist, sourced from Atropa belladonna, historically used to dilate pupils. This event directly links atropine to its role as an antagonist of muscarinic receptors, which is necessary to understand how it affects heart rate.\n\nEvent 5, while mentioning propranolol, a beta-adrenergic antagonist (beta blocker), does not directly relate to the mechanism of action of atropine or the relationship between muscarinic receptors and heart rate. Therefore, it is not relevant to the outcome described in event 12.",
    "choices": [
      "A",
      "B",
      "C"
    ]
  }
]